Cardinal Health, Inc. (CAH)
280.69
+2.55
(+0.92%)
USD |
NYSE |
Nov 13, 12:59
Cardinal Health Enterprise Value : 68.24B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 68.24B |
| November 11, 2026 | 68.08B |
| November 10, 2026 | 67.93B |
| November 09, 2026 | 67.35B |
| November 06, 2026 | 66.75B |
| November 05, 2026 | 65.84B |
| November 04, 2026 | 64.48B |
| November 03, 2026 | 62.39B |
| November 02, 2026 | 62.71B |
| October 30, 2026 | 61.82B |
| October 29, 2026 | 61.96B |
| October 28, 2026 | 60.49B |
| October 27, 2026 | 60.89B |
| October 26, 2026 | 62.07B |
| October 23, 2026 | 61.61B |
| October 22, 2026 | 63.02B |
| October 21, 2026 | 63.44B |
| October 20, 2026 | 63.46B |
| October 19, 2026 | 62.32B |
| October 16, 2026 | 62.65B |
| October 15, 2026 | 62.57B |
| October 14, 2026 | 61.19B |
| October 13, 2026 | 59.33B |
| October 12, 2026 | 58.94B |
| October 09, 2026 | 58.83B |
| Date | Value |
|---|---|
| October 08, 2026 | 59.15B |
| October 07, 2026 | 57.57B |
| October 06, 2026 | 57.87B |
| October 05, 2026 | 57.79B |
| October 02, 2026 | 56.68B |
| October 01, 2026 | 57.09B |
| September 30, 2026 | 55.33B |
| September 29, 2026 | 57.42B |
| September 28, 2026 | 56.58B |
| September 25, 2026 | 56.56B |
| September 24, 2026 | 57.12B |
| September 23, 2026 | 56.81B |
| September 22, 2026 | 56.99B |
| September 21, 2026 | 57.85B |
| September 18, 2026 | 57.76B |
| September 17, 2026 | 57.99B |
| September 16, 2026 | 59.43B |
| September 15, 2026 | 59.46B |
| September 14, 2026 | 59.98B |
| September 11, 2026 | 59.91B |
| September 10, 2026 | 60.24B |
| September 09, 2026 | 61.17B |
| September 08, 2026 | 61.29B |
| September 04, 2026 | 62.84B |
| September 03, 2026 | 63.18B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cencora, Inc. | 73.06B |
| McKesson Corp. | 131.34B |
| CVS Health Corp. | 175.53B |
| Amgen, Inc. | 293.45B |
| Henry Schein, Inc. | 14.80B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 556.00M |
| Revenue (Quarterly) | 67.51B |
| Total Expenses (Quarterly) | 66.96B |
| EPS Diluted (Quarterly) | 2.378 |
| Gross Profit Margin (Quarterly) | 3.70% |
| Profit Margin (Quarterly) | 0.82% |
| Earnings Yield | 2.75% |
| Operating Earnings Yield | 5.17% |
| Normalized Earnings Yield | 3.457 |